useful tool both to those who are considering collaborating with, or licensing technology from, a research university, and to university researchers who are contemplating the path to commercializing their climate change technology innovations.
2

Modes of University Research and Technology Transfer
University-based research in climate change technologies takes place in a variety of funding and collaboration structures. The particular structure governing a research project will have a significant impact on the intellectual property rights and technology transfer procedures applicable to that project. In this Section we outline several common modes of university research funding and technology transfer that are prevalent in the United States today. Funding organizations should be aware of the norms and structures of university research as described in this and subsequent Sections when deciding if funding university research will adequately promote their policy and intellectual property goals. Additionally, those interested in licensing climate change technologies should also be aware of the norms and structures of university research as these will effect the licensing terms under which the licensor can utilize the technology.
2.1
Grant Funding. The U.S. federal government funds between 62% and 68% of university research in the United States, primarily through grant mechanisms. 
University Research and the Bayh-Dole Act
Due to the dominance of federal funding of university research, inventors and investors interested in climate change technologies must understand the regulations surrounding the dissemination of federally funded research. In this Section we discuss specific practical, legal and intellectual property considerations that arise in the context of the federal funding described in Section 2.1.
3.1
A Brief History. Until World War II, university research in the U.S.
tended toward the theoretical and received relatively modest governmental support. 33 With the advent of the Manhattan Project, however, federal funding for research, and applied research in particular, increased dramatically. 34 In the decades that followed, numerous federal agencies began to fund university research; today the majority of university research is funded by the federal government, which contributed more than $32 billion to the research budgets of universities and non-profit research institutions in 2008. 35 Prior to 1980, rights in federally-funded inventions were governed by the rules of individual funding agencies and often inured to the agencies themselves. 36 Yet the federal government rarely put these inventions to commercial use, it being estimated that of the 30,000 federally-owned patents in existence prior to 1980, only five percent were ever licensed to industry and even fewer used in commercial products or services. 37 In response to this perceived underutilization of federally-funded research, the Bayh-Dole Act 38 was enacted in 1980. The purpose of the Act was to provide a consistent patent policy in regards to federally funded research and to promote the commercialization of resultant technologies. 39 The Act effected a major change in U.S. policy by allowing universities, small businesses and other research institutions to retain ownership of inventions resulting from federally funded research. In exchange for this grant of ownership, the Act requires these entities to apply for patent protection in the U.S. and abroad and imposes penalties for failing to take effective steps to achieve "practical application" of the inventions. 3.2.1 Invention Disclosure. The Act and its implementing regulations require that each federally-funded institution disclose to the relevant funding agency each invention reduced to practice within two months after it becomes known to the institution's patent administration personnel. 41 In order to support this obligation, each institution is also required to implement written agreements with its technical personnel (including faculty, technicians and students) requiring them to disclose all such inventions to the TLO. 42 Typically such agreements, which may be implemented in signed contracts or binding policy documents, also include an explicit assignment of intellectual property rights from the inventor to the university.
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Each university TLO submits invention disclosures to the applicable funding agencies, typically through the federal government's iEdison interagency web-based system, which accepts submissions for eighteen different federal agencies. 44 Invention disclosures and other information submitted to a federal agency pursuant to the BayhDole Act are treated as privileged and confidential and are not disclosed outside of the agency.
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A university's failure to comply with the disclosure requirements of the Act can result in the government's receiving title to the relevant invention. 46 In at least two litigated cases, courts have prohibited institutions from enforcing patents following a failure to comply with the disclosure requirements of the Bayh-Dole Act on the basis that the plaintiffs never acquired title to the patents in suit. 47 However, even in cases in which the government receives title to a federally-funded invention, the university retains a non- with non-U.S. university spin-outs, which are typically not subject to non-assignment prohibitions under local legislation.
3.2.6 Royalty-Sharing. The division of economic returns from university technology is typically handled internally by the university through its TLO.
The Bayh-Dole Act requires only that universities share royalties with individual inventors, without specifying the level or form of such sharing, and that the balance of these proceeds (after payment of expenses), "be utilized for the support of scientific research or education." 71 Royalty sharing arrangements vary widely among institutions.
For example, Stanford University allocates the first 15% of net license revenue (after patenting costs) to its TLO, then splits the remaining 85% in three equal parts among the inventors (in equal shares), their departments, and the university; Washington University in St. Louis allocates 25% to its TLO, 35% to the inventors and 40% to the university;
and Rice University allocates 37.5% to the inventors, 14% to their departments, 18.5% to the graduate education function, and 30% to the university. 72 While these arrangements are typically invisible to licensees, they become particularly important in arrangements involving collaboration by researchers at two or more universities. In such settings, institutions are often sensitive to perceived unequal treatment of collaborating researchers and must adjust their revenue sharing policies to account for differing expectations.
3.3
Accolades and Criticisms. The Bayh-Dole Act and the university technology transfer structure it formed has generated numerous accolades and criticisms.
Proponents of the Act contend that its encouragement of the patenting and licensing of federally-funded research has provided an effective framework for federal technology transfer, yielding economic benefits not just for universities and private industry, but for the U.S. economy as a whole. 73 A 2002 article in the Economist famously referred to the Bayh-Dole Act as "possibly the most inspired piece of legislation to be enacted in America over the past half-century". 74 The Biotechnology Industry Organization reported that, in the period from 1996 to 2007, university licensing to industry created over 279,000 jobs and contributed to over $457 billion in industry output. 75 79 For most universities, revenue from licensing barely covers the cost of staff and legal expenses associated with the process. 80 Furthermore, some critics contend that the race to patent university research, and the revenue generated by university-owned patents, has caused many universities to shift their focus from basic research to commercial development. 81 This shift, they argue, has led to a reduction in non- To-date, there is little definitive empirical evidence supporting either position. 83 Indisputable, however, is the fact that universities continue to develop innovations across a broad range of technologies, to obtain patent protection for those innovations (approximately 4,000 U.S. patents per year) 84 and to license those patents to the private sector for commercial application.
Other University Policy Considerations
Despite the frequent appearance of universities in the modern R&D landscape, universities are fundamentally different than corporate technology developers.
Universities operate on a not-for-profit basis, their missions are directed primarily toward research and education, and they are populated largely by academics, scientists and students. These unique characteristics distinguish university-based climate change technology development and exploitation and result in policies and practices that are significantly different than those found in commercial settings.
4.1
The Research Exemption.
A Narrow(ed) Exemption.
A university's ability to carry on research freely and without impediment is fundamental to its mission. A decade ago it was widely believed that academic research in the U.S. could be conducted without threat of patent infringement on the basis that pure research does not infringe the exclusive rights of a patent holder (i.e., the rights to make, use and sell a patented article and to perform a patented process). 85 This assumption was severely undermined by the Federal Circuit's 2002 decision in Madey v. Duke University. 86 In that case Professor Madey, a senior academic researcher, sued Duke, his former employer, for infringing several patents that Madey held in his own name. The alleged infringement involved Duke's continuing use of experimental laser equipment developed by Madey during and before his tenure at Duke. Duke asserted, among other things, that its use of the equipment had no commercial application and was directed solely to its non-profit research mission.
The court, while recognizing a limited judicial "experimental use" exemption from patent infringement, held that this exemption should be interpreted narrowly to exclude from infringement only activities that are carried out "for amusement, to satisfy idle curiosity, or for strictly philosophical inquiry." 87 Duke, it held, did not meet this standard, as its research was intended to further institutional business objectives such as educating students, improving its academic standing and attracting research grants, students and faculty. 88 As numerous commentators have observed, the Madey court's narrow reading of the experimental use exemption effectively eliminates its use in all but the most extreme cases, and does little to protect the research activities of any modern research university. believed to protect most non-commercial academic research. 90 In the aftermath of Madey, some commentators have called for the U.S. Congress to enact a broad patent immunity for research and experimental activity. 91 To date, Congress has acted only incrementally by exempting from infringement experimentation conducted in furtherance of regulatory submissions for drugs and veterinary products. 92 A more general legislative experimental use exemption does not currently appear to be on the horizon. 93 In addition to non-U.S. institutions, state-sponsored colleges and universities within the U.S., which are immune from suit in federal court under the Eleventh Amendment of the U.S. Constitution, cannot be sued for patent infringement. evidence also suggests that potential patent claims may deter research in certain areas. 97 If nothing else, university TLOs and legal offices have become significantly more aware of potential infringement issues. According to one report, the University of Iowa, in attempting to clear the research being conducted at a single laboratory studying rare ocular disorders, unearthed 71 different entities of concern and spent $24,000 on background checks and queries to patent holders. 98 Absent a change in the judicial interpretation of the experimental use exemption, universities are likely exposed to some level of risk from infringement of third party patents. Such exposure may be unavoidable for the university that wishes to conduct research at the cutting edge of science. What is avoidable, however, is the risk that universities face from the patents on their own inventions. There have been recent examples of universities that, whether through inadvertence or carelessness, licensed inventions for exclusive use by industrial partners, thereby blocking any further use or development by the university laboratory that originated them. 99 To avoid such situations, most universities now require standard language in all license agreements that reserve the university's right to exploit licensed inventions for their own non-commercial research and educational purposes. 100 In 2007, a group of major research universities together with the Association of American Medical Colleges (AAMC) released a document setting forth nine principles relevant to the licensing of academic technology "in the public interest and for society's benefit" (the "Nine Points Document"). 101 The first of these principles calls for universities not only to retain through their licensing agreements the right to practice licensed inventions, but also to extend such rights to any other non-profit or governmental organization. 102 The Nine
Points Document goes so far as to suggest that even research sponsored by commercial entities should be permitted, so long as it is conducted by a non-profit entity. Ordinarily, such a reservation of rights would benefit a third party university only if the licensing university granted it a license under the relevant patents. However, the Nine Points Document, which has now been endorsed by over 70 universities, also suggests an approach whereby any industrial licensee would contractually agree not to enforce a licensed patent against any university or other non-profit institution. 103 Additionally, some funding organizations such as the NIH and the California Institute for Regenerative Medicine, are encouraging the creation of contractually-based research exemptions for non-commercial research. 104 Should such contractual language be adopted widely by universities, a broad, contractually-constructed experimental use exemption could emerge where Congress has failed to recognize one. A scientific publication typically includes a brief presentation of significant experimental findings, often made in summary or tabular fashion, together with the scientist's analysis and conclusions based upon those findings. 106 While the published data are usually essential to support the scientist's analysis, the data reported in a journal article seldom represent the entirety of the "raw" data collected or observed by the scientist, and are typically only a small fraction of the full data set. Over the past decade, however, an increasing number of scientific journals have required that authors make the data supporting their published claims available to readers upon request. 107 In certain fields such as genomics, government funding agencies routinely require the deposit of raw data sets into public databases, 108 and there are numerous initiatives to encourage the sharing of observational and experimental data in the atmospheric and climatological sciences. 109 It is likely that this trend toward broad sharing of, and public access to, scientific data concerning climate change will continue through a combination of journal requirements, funding obligations and academic agreements. While current university initiatives have focused on access to essential medicines, commentators have suggested that similar considerations should also apply with respect to climate change technologies, which are also likely to have a profound effect on human health and welfare, both in the developed and the developing world. 114 Certainly the public debate over international intellectual property policy and climate change technology echo the earlier (and ongoing) debate regarding access to essential medicines in developing countries. 115 Thus, it is likely that considerations of socially-responsible licensing will enter into university sponsored research and licensing agreements for climate change technologies in the not-too-distant future.
Potential licensing structures that might emerge, as suggested by the experience of essential medicines, include (a) excluding developing countries from exclusive license grants, (b) requiring licensees to grant sublicenses to local producers in developing countries, (c) retaining university private march-in rights if products are not made suitably accessible in developing countries, and (d) prohibiting the filing of corresponding patent applications in developing countries. 116 Other contractual approaches that may achieve socially-responsible goals include university patent pledges and non-assertion covenants such as those expressed in the Eco-Patent Commons (described in Section 2.6 above), as well as the contribution of patents to sociallyoriented patent pools along the lines of the newly-formed UNITAID pool for essential medicines.
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Conclusion
Research universities have traditionally been catalysts for technological innovation and are likely to generate significant advances in climate change technology for decades to come. However, unlike commercial enterprises, universities are subject to significant limitations and obligations arising from federal funding requirements, statutory regimes such as the Bayh-Dole Act, and the dictates of their non-profit charters.
It is important to keep these particular characteristics of universities and university research in mind when considering any collaboration, license or sponsorship arrangement with them. If appropriate consideration is given to these characteristics, however, substantial benefits may be derived for industry, academia and society as a whole.
